An alternative HER-2/neu transcript of 8 kb has an extended 3'UTR and displays increased stability in SKOV-3 ovarian carcinoma cells.

作者: Joni K. Doherty , Chris T. Bond , Wenhui Hua , John P. Adelman , Gail M. Clinton

DOI: 10.1006/GYNO.1999.5467

关键词: ExonPrimary transcriptMessenger RNAMolecular biologyGeneCoding regionTranscription (biology)Gene rearrangementRapid amplification of cDNA endsBiology

摘要: Abstract HER-2/ neu is a potent oncogene that predicts poor outcome when overexpressed in ovarian cancer. The SKOV-3 carcinoma cell line, one of the only models for HER2-driven cancer, expresses major uncharacterized 8-kb alternative HER-2 transcript. Objectives. aim this study was to characterize structure and determine origin sequence examine possible role transcript overexpression gene. Methods. investigated using polymerase chain reaction (PCR) nucleotide sequencing cDNA clones. PCR analysis genomic DNA used assess stability mRNA assessed by Northern blot RNA extracted from cells treated with transcriptional inhibitors. Results. Similar 5′UTR coding but an extended 3′UTR were contained compared well-characterized 4.5-kb Genomic had continuity between novel adjacent terminal exon sequence. half-life 13 h 5.5 ( P Conclusions. generated polyadenylation site usage rather than gene rearrangement. Since contains found at 3′ end normal gene, it could be expressed other cells. Increased may confer selective advantage providing enhanced expression.

参考文章(35)
D. Gershenson, M. C. Hung, X. Zhang, E. Silva, Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. Oncogene. ,vol. 4, pp. 985- 989 ,(1989)
James Berenson, Joseph F. Gera, Otoniel Martinez-Maza, Jonathan S. Berek, Kristine Waldburger, Alan Lichtenstein, Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes. Cancer Research. ,vol. 50, pp. 7364- 7370 ,(1990)
W. C. Dougall, A. Samanta, Xiaolan Qian, M. I. Greene, N. C. Peterson, M. J. Miller, The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene. ,vol. 9, pp. 2109- 2123 ,(1994)
O Segatto, C R King, J H Pierce, P P Di Fiore, S A Aaronson, Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Molecular and Cellular Biology. ,vol. 8, pp. 5570- 5574 ,(1988) , 10.1128/MCB.8.12.5570
R. M. Hudziak, J. Schlessinger, A. Ullrich, Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7159- 7163 ,(1987) , 10.1073/PNAS.84.20.7159
Alan B. Sachs, Messenger RNA degradation in eukaryotes Cell. ,vol. 74, pp. 413- 421 ,(1993) , 10.1016/0092-8674(93)80043-E
C. Lin, W. Chen, W Kruiger, L. Stolarsky, W Weber, R. Evans, I. Verma, G. Gill, M. Rosenfeld, Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells Science. ,vol. 224, pp. 843- 848 ,(1984) , 10.1126/SCIENCE.6326261
C. T. Guy, M. A. Webster, M. Schaller, T. J. Parsons, R. D. Cardiff, W. J. Muller, Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 10578- 10582 ,(1992) , 10.1073/PNAS.89.22.10578